BioCentury
ARTICLE | Clinical News

VT-1161: Interim Phase IIb data

March 14, 2016 7:00 AM UTC

Interim data from about 100 patients with distal lateral subungual onychomycosis of the large toenail in the double-blind, U.S. Phase IIb RENOVATE trial showed that 300 and 600 mg oral VT-1161 once da...